Overview

Dynamic Hyperinflation and Tiotropium

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
We will detect dynamic hyperinflation (DH) in 40 COPD (chronic obstructive pulmonary disease) patients with moderately severe disease using metronome paced hyperventilation (MPH) with inspiratory capacity as the primary end point. Hypothesis: Is tiotropium capable of lung volume protecting inspiratory capacity from MPH induced DH vs placebo in a randomized crossover double blinded study.
Phase:
Phase 4
Details
Lead Sponsor:
Gelb, Arthur F., M.D.
Collaborators:
Boehringer Ingelheim
Pfizer
Treatments:
Tiotropium Bromide